CD36 and neoplasm: They have suggested that reduced CD36 expression across multiple stromal cell types results in a complex, coordinated set of signalling pathways which increases the risk of tumour development via a variety of mechanisms including adipocyte differentiation, angiogenesis, cell-ECM interaction and immune signalling.